Plaintiff Attorneys Vie for Leadership Roles in Dupixent MDL Over Cancer Claims
Attorneys are competing for leadership posts in the Dupixent MDL, where plaintiffs allege Sanofi and Regeneron failed to warn about cancer risks tied to the blockbuster eczema biologic.